A Study To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Study in Men With Premature Ejaculation
Clinical trial NCT01021553 · COMPLETED
Trial details
- NCT number
- NCT01021553
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-23
- Primary completion
- 2011-05-05
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.